|
Volumn 23, Issue 6, 2001, Pages 863-864
|
Effect of pioglitazone on dyslipidemia in hemodialysis patients with type 2 diabetes
a a a a a a
a
KOTO HOSPITAL
(Japan)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
DIACYLGLYCEROL;
GLIBENCLAMIDE;
GLUCOSE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PIOGLITAZONE;
PLACEBO;
PROTEIN KINASE C;
THIAZOLIDINE DERIVATIVE;
TRIACYLGLYCEROL;
VOGLIBOSE;
ADULT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC NEPHROPATHY;
DRUG EFFECT;
DYSLIPIDEMIA;
ENZYME ACTIVATION;
FEMALE;
HEMODIALYSIS PATIENT;
HUMAN;
INSULIN RESISTANCE;
LETTER;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL;
TRIACYLGLYCEROL BLOOD LEVEL;
CHOLESTEROL, HDL;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLYBURIDE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPERLIPIDEMIAS;
HYPOGLYCEMIC AGENTS;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
THIAZOLES;
THIAZOLIDINEDIONES;
TRIGLYCERIDES;
|
EID: 0035659064
PISSN: 0886022X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (7)
|
References (7)
|